PhaseBio Pharmaceuticals, Inc. (PHAS)

Total Assets

$22.17M

Quarterly · Period ending: · USD

PHAS logo

PHAS Total Assets

Latest reported$22.17M
PHAS Quarterly Total Assets ($14.10M → $22.17M)
High-resolution chart · PNG

PHAS total assets history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

PhaseBio Pharmaceuticals, Inc. Total Assets — Quarterly (USD)
Period endingTotal Assets (USD)
22,166,000
38,664,000
60,540,000
77,725,000
100,637,000
100,821,000
50,357,000
58,207,000
70,810,000
76,858,000
82,494,000
86,203,000
97,438,000
56,386,000
63,026,000
27,488,000
29,601,000
14,099,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.